Maximino Redondo

Prof. Dr. Maximino Redondo

orcid

Research Focus & Metrics

Academic Career Length

38Years (1989-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2000 in The American Journal of Pathology
Verified
Journal Article
Closed access
MRMaximino Redondo
Maximino Redondo
EVEduardo Villar
Eduardo Villar
JTJorge Torres-Muñoz
Jorge Torres-Muñoz
TSTeresa Tellez Santana
Teresa Tellez Santana
MMMiguel Morell
Miguel Morell
CPCarol K. Petito
Carol K. Petito

20 November 2019 in Cancers
Verified
Journal Article
Open access
PDF file
MGMarilina García-Aranda
Marilina García-Aranda
MRMaximino Redondo
Maximino Redondo
Breast cancer is the most commonly diagnosed cancer in women and is a leading cause of cancer death in women worldwide. Despite the significant benefit of the use of conventional chemotherapy and monoclonal antibodies in the prognosis of breast cancer patients and although the recent approval of the anti-PD-L1 antibody atezolizumab in combination with chemotherapy has been a milestone for the treatment of patients with metastatic triple-negative breast cancer, immunologic treatment of breast tumors remains a great challenge. In this review, we summarize current breast cancer classification and standard of care, the main obstacles that hinder the success of immunotherapies in breast cancer patients, as well as different approaches that could be useful to enhance the response of breast tumors to immunotherapies.

Verified
Journal Article
Open access
PDF file
MGMarilina García-Aranda
Marilina García-Aranda
EPElisabeth Perez-Ruiz
Elisabeth Perez-Ruiz
MRMaximino Redondo
Maximino Redondo
A bstract: According to the World Health Organization (WHO), cancer is a leading cause of death worldwide. The identification of novel targets for cancer treatment is an area of intense work that has led Bcl-2 over-expression to be proposed as one of the hallmarks of cancer and Bcl-2 inhibition as a promising strategy for cancer treatment. In this review, we describe the different pathways related to programmed cell death, the role of Bcl-2 family members in apoptosis resistance to anti-cancer treatments, and the potential utility of Bcl-2 inhibitors to overcome resistance to chemo- and immunotherapy.

1 October 2008 in Molecular and Cellular Neuroscience
Verified
Journal Article
Closed access
EMElisa Matas-Rico
Elisa Matas-Rico
BDBeatriz Garcia Diaz
Beatriz Garcia Diaz
PLPedro Llebrez-Zayas
Pedro Llebrez-Zayas
DLDiana Lopez-Barroso
Diana Lopez-Barroso
LSLuis Javier Santín-Núñez
Luis Javier Santín-Núñez
Guillermo Estivill-TorrúsGuillermo Estivill-Torrús
Guillermo Estivill-Torrús

Verified
Journal Article
Open access
PDF file
ABAntonio M. Burgos-Molina
Antonio M. Burgos-Molina
TSTeresa Tellez Santana
Teresa Tellez Santana
MRMaximino Redondo
Maximino Redondo
MRMaría José Bravo Romero
María José Bravo Romero
Chronic inflammation drives the growth of colorectal cancer through the dysregulation of molecular pathways within the immune system. Infiltration of immune cells, such as macrophages, into tumoral regions results in the release of proinflammatory cytokines (IL-6; IL-17; TNF-α), fostering tumor proliferation, survival, and invasion. Tumors employ various mechanisms to evade immune surveillance, effectively ‘cloaking’ themselves from detection and subsequent attack. A comprehensive understanding of these intricate molecular interactions is paramount for advancing novel strategies aimed at modulating the immune response against cancer.

27 May 2003 in British Journal of Cancer
Verified
Journal Article
Open access
PDF file
ELE Perea-Milla López
E Perea-Milla López
RMR M Miñarro-Del Moral
R M Miñarro-Del Moral
CMC Martínez-García
C Martínez-García
RZR Zanetti
R Zanetti
SRS Rosso
S Rosso
MRMaximino Redondo
Maximino Redondo
The aim of this study was to identify factors related to lip cancer (LC) considering individual characteristics and sociodemographic factors. A case–control study was carried out in the province of Granada (Andalusia, southern Spain). The cases were 105 males with squamous-cell carcinoma of the lip, diagnosed between 1987 and 1989 (aged 20–70 years) and identified by means of a population-based Cancer Registry. As controls, a randomised populational sample of 239 males, stratified by age, was used. Multiple logistic regression analysis showed that risk factors are lifetime cumulative tobacco consumption and alcohol consumption. An interaction was found between alcohol consumption and the smoking habit (leaving the cigarette on the lip): OR=23.6; 95% CI: 3.9–142.0. Other risk factors identified are clear eyes (OR=3.5; CI: 95% 1.5–8.0), sun exposure early in life and cumulative sun exposure during outdoor work (OR=11.9; 95%: CI: 1.3–108.9), and skin reaction to sun exposure (Fitzpatrick levels). Another interaction was found between skin reaction and a previous history of common sporadic warts (OR=4.4; 95% CI: 1.01–19.1). We conclude that LC is related to phenotype, skin reaction to sun exposure, cumulative and early sunlight exposure, and tobacco and alcohol consumption, as well as a low educational level. Leaving the cigarette on the lip is predictive of LC risk irrespective of cumulative tobacco consumption.